PSMA PET-CT use prior to systemic therapy in metastatic Castration-Resistant Prostate Cancer (mCRPC). Kelly R, Jensen A, Karunaratna N, Wong S, et al. BJU Int 2022 Nov 13. doi: 10.1111/bju.15930.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kelly R, Jensen A, Karunaratna N, Wong S, et al. PSMA PET-CT use prior to systemic therapy in metastatic Castration-Resistant Prostate Cancer (mCRPC). BJU Int 2022 Nov 13. doi: 10.1111/bju.15930.
PMID: 36371671